Comparing the Effectiveness of a Treat-to-target (T2T) Disease Management Strategy vs. Routine Care (RC) in Adult Patients With Moderate to Severe Rheumatoid Arthritis (RA) Treated With Subcutaneous Abatacept (Orencia - SC)
Clinical trial NCT03274141 · COMPLETED
Trial details
- NCT number
- NCT03274141
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2011-10-31
- Primary completion
- 2018-10-31
- Enrollment
- 281
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.